Advertisement

Biotechnology firm Microbix Biosystems Inc. (TSX:MBX) second-quarter net loss increases slightly to $1.4 million from year-ago $1.3 million; revenues down four per cent to $1.76 million as sales slide 16 per cent on one-time reduction in purchases by large customer. Says issues have arisen in Chinese joint venture.

Advertisement
Advertisement